LifeVantage, a science-based nutraceutical company, has reported net sales of $9.98m for the fiscal third quarter ended 31 March of 2011, an increase of 270%, compared to $2.72m for the same period in 2010.
The company has posted net loss of $9.77m, compared to $8.25m for the same period previous year.
Gross profit was $8.39m, compared to $2.28m for the same period last year.
LifeVantage's operating income was $792,263, as compared to operating loss of $1.34m for the comparable period prior year.
For the nine months ended 31 March 2011, the company's net sales were $23.88m, compared to $7.04m for the same period last year.
The company has posted net loss of $3.6m, compared to $6.06m for the same period in the previous year.
LifeVantage's gross profit was $20.09m, compared to $5.86m for the same period in the prior year.
The company has reported operating income of $1.75m, compared to operating loss of $7.03m for the comparable period last year.
LifeVantage CEO Douglas Robinson said their continued financial performance gives them the confidence to remain optimistic about the outlook for the remainder of fiscal 2011.
"We believe the investments we are making into our sales and marketing, research, development and support personnel will enable us to increase our reach into new and existing consumer markets as well as introduce new products, leveraging our many years of research towards our goal of helping people around the world achieve improved health and wellness," Robinson said.
LifeVantage offers two anti-aging and wellness products Protandim and TrueScience Anti-Aging Cream.
Protandim is a dietary supplement that combats oxidative stress. TrueScience Anti-Aging Cream is a scientifically based skin care product.